Dr. Douglas Simonetto, MD
Claim this profileMayo Clinic
Studies Liver Cirrhosis
Studies Diabetic Liver Disease
7 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Douglas Simonetto, MD is currently running
INT-787
for Alcoholic Hepatitis
This trial tests a new drug called INT-787 for people with severe liver damage from heavy drinking. It aims to see if the drug is safe and effective, and how the body processes it. The goal is to find out if INT-787 can help improve liver health in these patients. Previous studies have shown that similar treatments can protect against liver injury.
Recruiting0 awards Phase 2
Digital Clinic
for Alcoholism and Liver Disease
The purpose of this study is to determine whether a multidisciplinary digital clinic will improve health outcomes, reduce costs, increase access, and improve provider satisfaction. The primary aim of this study is to improve clinical outcomes in patients with ALD through the implementation of a novel digital health platform for personalized multi-disciplinary treatment of patients with ALD and AUD. Secondary aims include improvement in provider and patient-reported outcomes including satisfaction with AUD treatment.
Recruiting1 award N/A
More about Douglas Simonetto, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Douglas Simonetto, MD has experience with
- DALC Digital Clinic
- ACE 2.0
- PHIN-214
- BIV201
- Terlipressin
- INT-787
Breakdown of trials Douglas Simonetto, MD has run
Liver Cirrhosis
Diabetic Liver Disease
Cirrhosis
Ascites
Alcohol Abuse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Douglas Simonetto, MD specialize in?
Douglas Simonetto, MD focuses on Liver Cirrhosis and Diabetic Liver Disease. In particular, much of their work with Liver Cirrhosis has involved treating patients, or patients who are undergoing treatment.
Is Douglas Simonetto, MD currently recruiting for clinical trials?
Yes, Douglas Simonetto, MD is currently recruiting for 3 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Douglas Simonetto, MD has studied deeply?
Yes, Douglas Simonetto, MD has studied treatments such as DALC Digital Clinic, ACE 2.0, PHIN-214.
What is the best way to schedule an appointment with Douglas Simonetto, MD?
Apply for one of the trials that Douglas Simonetto, MD is conducting.
What is the office address of Douglas Simonetto, MD?
The office of Douglas Simonetto, MD is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.